跳至主要内容
临床试验/EUCTR2015-004311-20-SE
EUCTR2015-004311-20-SE进行中(未招募)不适用

Effect of vitamin B substitution on plasma NFL and neurocognitive performance in HIV-infected individuals with increased plasma homocysteine

Gothenburg University0 个研究点开始时间: 2016年1月14日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. The ability to understand and give informed consent to participate.
  • 2. Stable ART > 12 months
  • 3. Plasma HIV-RNA <50 copies/ml
  • 4. Elevated plasma homocysteine
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 45
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • 1. Treatment with trimethoprim-sulfamethoxazole or methotrexate
  • 2. Ongoing B6, B12 or folate substitution
  • 3. Antiepileptic treatment
  • 4. Small bowel or ventricular resection
  • 5. Disturbed absorption in small bowel (Mb Crohn, untreated coeliac disease)
  • 6. Ongoing neurological disease or severe psychiatric disease
  • 7. Any malignant tumor in the history.
  • 8. Severe ongoing infection or opportunistic infection
  • 9. Pregnancy
  • 10. AUDIT > 7 for men and > 5 for women
  • 11. MADRS > 20
  • 12. Significant B12 or folate deficiency that indicate substitution

研究者

发起方
Gothenburg University

相似试验